Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-06 for acute pain associated with herpes zoster
jRCT2041220047Phase 3Active, not recruiting
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Sep 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in herpes zoster (HZ) comparing NPC-06 (fosphenytoin) arm with Placebo arm (2 arms). Started Sep 2022; status: active, not recruiting.
02
Drugs
fosphenytoin
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on jRCT2041220047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041220047.